PCA
Private Capital Advisors Portfolio holdings
AUM
$821M
This Quarter Return
+20.5%
1 Year Return
+5.72%
3 Year Return
+100.45%
5 Year Return
+227.97%
10 Year Return
+492.43%
AUM
$386M
AUM Growth
+$386M
(+22%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
3.14%
Top 10 Holdings %
Top 10 Hldgs %
52.34%
Holding
89
New
14
Increased
8
Reduced
20
Closed
4
Top Buys
| 1 |
RTX Corp
RTX
|
$11M |
| 2 |
Dover
DOV
|
$8.39M |
| 3 |
Energy Transfer Partners
ET
|
$3.54M |
| 4 |
Lazard
LAZ
|
$3.29M |
| 5 |
Enterprise Products Partners
EPD
|
$2.24M |
Top Sells
| 1 |
RTN
Raytheon Company
RTN
|
$10M |
| 2 |
Comcast
CMCSA
|
$6.1M |
| 3 |
UBA
Urstadt Biddle Properties Inc. Class A
UBA
|
$1.68M |
| 4 |
Blackstone
BX
|
$1.37M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$597K |
Sector Composition
| 1 | Healthcare | 37.69% |
| 2 | Technology | 17.36% |
| 3 | Industrials | 14.02% |
| 4 | Communication Services | 10.27% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $55M | 14.24% |
334,724
-1,000
| -0.3% | -$164K |
|
2
Apple
AAPL
$3.45T
| $32.9M | 8.52% |
90,157
-550
| -0.6% | -$201K |
|
3
Meta Platforms (Facebook)
META
$1.86T
| $16.3M | 4.21% |
71,574
-2,423
| -3% | -$550K |
|
|
4
Blackstone
BX
$134B
| $16.2M | 4.21% |
286,558
-24,250
| -8% | -$1.37M |
|
|
5
Alphabet (Google) Class A
GOOGL
$2.57T
| $15.6M | 4.04% |
10,997
-421
| -4% | -$597K |
|
6
Cisco
CSCO
$274B
| $14.7M | 3.81% |
314,758
-10,562
| -3% | -$493K |
|
7
Thermo Fisher Scientific
TMO
$186B
| $13.5M | 3.49% |
37,184
| – | – |
|
8
UnitedHealth
UNH
$281B
| $12.9M | 3.34% |
43,714
-100
| -0.2% | -$29.5K |
|
9
Intel
INTC
$107B
| $12.5M | 3.25% |
209,635
-300
| -0.1% | -$17.9K |
|
10
AbbVie
ABBV
$372B
| $12.4M | 3.22% |
126,521
-1,000
| -0.8% | -$98.2K |
|
11
Lockheed Martin
LMT
$106B
| $12.1M | 3.14% |
33,225
-305
| -0.9% | -$111K |
|
|
12
RTX Corp
RTX
$212B
| $11M | 2.84% |
+177,801
| New | +$11M |
|
13
Cigna
CI
$80.3B
| $10.9M | 2.82% |
57,976
-150
| -0.3% | -$28.1K |
|
14
Amgen
AMGN
$155B
| $8.99M | 2.33% |
38,117
-50
| -0.1% | -$11.8K |
|
|
15
Enterprise Products Partners
EPD
$69.6B
| $8.88M | 2.3% |
488,928
+123,099
| +34% | +$2.24M |
|
|
16
Lazard
LAZ
$5.39B
| $8.8M | 2.28% |
307,245
+115,066
| +60% | +$3.29M |
|
|
17
Dover
DOV
$24.5B
| $8.39M | 2.17% |
+86,875
| New | +$8.39M |
|
|
18
Energy Transfer Partners
ET
$60.8B
| $8.11M | 2.1% |
1,138,857
+497,237
| +77% | +$3.54M |
|
19
Danaher
DHR
$147B
| $7.99M | 2.07% |
45,192
| – | – |
|
20
Northrop Grumman
NOC
$84.5B
| $7.94M | 2.06% |
25,831
-50
| -0.2% | -$15.4K |
|
21
Merck
MRK
$210B
| $7.85M | 2.04% |
101,559
-1,641
| -2% | -$127K |
|
22
Union Pacific
UNP
$133B
| $7.09M | 1.84% |
41,905
| – | – |
|
|
WRK
23
DELISTED
WestRock Company
WRK
| $6.2M | 1.61% |
219,438
-1,340
| -0.6% | -$37.9K |
|
24
JPMorgan Chase
JPM
$829B
| $6.15M | 1.59% |
65,392
+3,302
| +5% | +$311K |
|
25
Pfizer
PFE
$141B
| $5.68M | 1.47% |
173,742
+6,609
| +4% | +$216K |
|